HIVE DIGITAL TECHNOLOGIES LT (HIVE) Fundamental Analysis & Valuation

NASDAQ:HIVE • CA4339211035

Current stock price

2.095 USD
+0.03 (+1.21%)
Last:

This HIVE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. HIVE Profitability Analysis

1.1 Basic Checks

  • HIVE had negative earnings in the past year.
  • HIVE had a positive operating cash flow in the past year.
  • In multiple years HIVE reported negative net income over the last 5 years.
  • Each year in the past 5 years HIVE had a positive operating cash flow.
HIVE Yearly Net Income VS EBIT VS OCF VS FCFHIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

1.2 Ratios

  • The Return On Assets of HIVE (-11.53%) is worse than 65.45% of its industry peers.
  • HIVE has a Return On Equity (-12.87%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -11.53%
ROE -12.87%
ROIC N/A
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
HIVE Yearly ROA, ROE, ROICHIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HIVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIVE Yearly Profit, Operating, Gross MarginsHIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. HIVE Health Analysis

2.1 Basic Checks

  • HIVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for HIVE has been increased compared to 1 year ago.
  • HIVE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, HIVE has an improved debt to assets ratio.
HIVE Yearly Shares OutstandingHIVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HIVE Yearly Total Debt VS Total AssetsHIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • HIVE has an Altman-Z score of 4.17. This indicates that HIVE is financially healthy and has little risk of bankruptcy at the moment.
  • HIVE has a better Altman-Z score (4.17) than 73.09% of its industry peers.
  • HIVE has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • HIVE's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. HIVE outperforms 60.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 4.17
ROIC/WACCN/A
WACC9.91%
HIVE Yearly LT Debt VS Equity VS FCFHIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.74 indicates that HIVE should not have too much problems paying its short term obligations.
  • HIVE has a Current ratio (1.74) which is in line with its industry peers.
  • A Quick Ratio of 1.74 indicates that HIVE should not have too much problems paying its short term obligations.
  • HIVE has a Quick ratio (1.74) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
HIVE Yearly Current Assets VS Current LiabilitesHIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. HIVE Growth Analysis

3.1 Past

  • The earnings per share for HIVE have decreased strongly by -763.33% in the last year.
  • The Revenue has grown by 112.51% in the past year. This is a very strong growth!
  • Measured over the past years, HIVE shows a very strong growth in Revenue. The Revenue has been growing by 31.59% on average per year.
EPS 1Y (TTM)-763.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3800%
Revenue 1Y (TTM)112.51%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%218.56%

3.2 Future

  • The Earnings Per Share is expected to decrease by -309.31% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 73.55% on average over the next years. This is a very strong growth
EPS Next Y-2185.79%
EPS Next 2Y-385.82%
EPS Next 3Y-309.31%
EPS Next 5YN/A
Revenue Next Year166.46%
Revenue Next 2Y92.76%
Revenue Next 3Y73.55%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HIVE Yearly Revenue VS EstimatesHIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
HIVE Yearly EPS VS EstimatesHIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. HIVE Valuation Analysis

4.1 Price/Earnings Ratio

  • HIVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year HIVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HIVE Price Earnings VS Forward Price EarningsHIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HIVE is valued cheaply inside the industry as 88.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.06
HIVE Per share dataHIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • A cheap valuation may be justified as HIVE's earnings are expected to decrease with -309.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-385.82%
EPS Next 3Y-309.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIVE Dividend Analysis

5.1 Amount

  • HIVE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIVE Fundamentals: All Metrics, Ratios and Statistics

HIVE DIGITAL TECHNOLOGIES LT

NASDAQ:HIVE (4/9/2026, 2:52:40 PM)

2.095

+0.03 (+1.21%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-15
Earnings (Next)06-24
Inst Owners33.02%
Inst Owner Change0%
Ins Owners0.43%
Ins Owner Change0%
Market Cap536.86M
Revenue(TTM)257.14M
Net Income(TTM)-71.97M
Analysts80
Price Target4.76 (127.21%)
Short Float %11.05%
Short Ratio2.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-254.08%
Min EPS beat(2)-423.34%
Max EPS beat(2)-84.82%
EPS beat(4)2
Avg EPS beat(4)-34.38%
Min EPS beat(4)-423.34%
Max EPS beat(4)269.73%
EPS beat(8)6
Avg EPS beat(8)19.63%
EPS beat(12)8
Avg EPS beat(12)17.68%
EPS beat(16)9
Avg EPS beat(16)-129.51%
Revenue beat(2)1
Avg Revenue beat(2)5.59%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)16.9%
Revenue beat(4)2
Avg Revenue beat(4)3.24%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)16.9%
Revenue beat(8)5
Avg Revenue beat(8)4.17%
Revenue beat(12)8
Avg Revenue beat(12)4.05%
Revenue beat(16)11
Avg Revenue beat(16)14.48%
PT rev (1m)0%
PT rev (3m)-26.36%
EPS NQ rev (1m)-9.57%
EPS NQ rev (3m)-174.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-303.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.09
P/FCF N/A
P/OCF 6.25
P/B 0.96
P/tB 0.96
EV/EBITDA 9.06
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)0.33
OCFY15.99%
SpS1
BVpS2.18
TBVpS2.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.53%
ROE -12.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.3
Cap/Depr 140.42%
Cap/Sales 72.89%
Interest Coverage N/A
Cash Conversion 183.62%
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 4.17
F-Score5
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)97.27%
Cap/Depr(5y)157.57%
Cap/Sales(3y)54.64%
Cap/Sales(5y)58.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-763.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3800%
EPS Next Y-2185.79%
EPS Next 2Y-385.82%
EPS Next 3Y-309.31%
EPS Next 5YN/A
Revenue 1Y (TTM)112.51%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%218.56%
Revenue Next Year166.46%
Revenue Next 2Y92.76%
Revenue Next 3Y73.55%
Revenue Next 5YN/A
EBIT growth 1Y-67.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year253.98%
EBIT Next 3Y75.31%
EBIT Next 5YN/A
FCF growth 1Y-516.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y174.74%
OCF growth 3Y-36.92%
OCF growth 5Y84.91%

HIVE DIGITAL TECHNOLOGIES LT / HIVE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HIVE DIGITAL TECHNOLOGIES LT?

ChartMill assigns a fundamental rating of 3 / 10 to HIVE.


Can you provide the valuation status for HIVE DIGITAL TECHNOLOGIES LT?

ChartMill assigns a valuation rating of 1 / 10 to HIVE DIGITAL TECHNOLOGIES LT (HIVE). This can be considered as Overvalued.


What is the profitability of HIVE stock?

HIVE DIGITAL TECHNOLOGIES LT (HIVE) has a profitability rating of 2 / 10.


How financially healthy is HIVE DIGITAL TECHNOLOGIES LT?

The financial health rating of HIVE DIGITAL TECHNOLOGIES LT (HIVE) is 4 / 10.